110 likes | 295 Views
“Epilepsy - Pipeline Review, H2 2014”, provides an overview of the Epilepsys therapeutic pipeline. For more details : http://goo.gl/3U1CGu
E N D
Aarkstore - Epilepsy - Pipeline Review, H2 2014 www.aarkstore.com
Summary “Epilepsy - Pipeline Review, H2 2014”, provides an overview of the Epilepsys therapeutic pipeline. This Market Research Report provides comprehensive information on the therapeutic development for Epilepsy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Epilepsy and special features on late stage and discontinued projects. www.aarkstore.com
Scope - The report provides a snapshot of the global therapeutic landscape of Epilepsy- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Epilepsy and enlists all their major and minor projects- The report summarizes all the dormant and discontinued pipeline projects - A review of the Epilepsy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages- A detailed assessment of monotherapy and combination therapy pipeline projects- Coverage of the Epilepsy pipeline on the basis of target, MoA, route of administration and molecule type- Latest news and deals relating related to pipeline products www.aarkstore.com
Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage- Develop strategic initiatives by understanding the focus areas of leading companies- Identify and understand important and diverse types of therapeutics under development for Epilepsy- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline- Devise corrective measures for pipeline projects by understanding Epilepsy pipeline depth and focus of Indication therapeutics- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline www.aarkstore.com
Table of Contents Introduction 8Global Markets Direct Report Coverage 8Epilepsy Overview 9Therapeutics Development 10Pipeline Products for Epilepsy - Overview 10Pipeline Products for Epilepsy - Comparative Analysis 11Epilepsy - Therapeutics under Development by Companies 12Epilepsy - Therapeutics under Investigation by Universities/Institutes 17Epilepsy - Pipeline Products Glance 19Late Stage Products 19Clinical Stage Products 20Early Stage Products 21Epilepsy - Products under Development by Companies 22 www.aarkstore.com
List Of Tables Number of Products under Development for Epilepsy, H2 2014 17Number of Products under Development for Epilepsy - Comparative Analysis, H2 2014 18Number of Products under Development by Companies, H2 2014 20Number of Products under Development by Companies, H2 2014 (Contd..1) 21Number of Products under Development by Companies, H2 2014 (Contd..2) 22Number of Products under Development by Companies, H2 2014 (Contd..3) 23Number of Products under Investigation by Universities/Institutes, H2 2014 25Comparative Analysis by Late Stage Development, H2 2014 26Comparative Analysis by Clinical Stage Development, H2 2014 27Comparative Analysis by Early Stage Development, H2 2014 28 www.aarkstore.com
List Of Figures Number of Products under Development for Epilepsy, H2 2014 17Number of Products under Development for Epilepsy - Comparative Analysis, H2 2014 18Number of Products under Development by Companies, H2 2014 19Number of Products under Investigation by Universities/Institutes, H2 2014 24Comparative Analysis by Late Stage Development, H2 2014 26Comparative Analysis by Clinical Stage Development, H2 2014 27Comparative Analysis by Early Stage Products, H2 2014 28Assessment by Monotherapy Products, H2 2014 75Number of Products by Top 10 Target, H2 2014 76Number of Products by Stage and Top 10 Target, H2 2014 77 www.aarkstore.com
Related Market Research reports: • Blirt S.A. - Product Pipeline Review – 2014 • Auris Medical Holding AG - Product Pipeline Review – 2014 • Integral Molecular, Inc. - Product Pipeline Review – 2014 • DaVinci Biosciences, LLC - Product Pipeline Review – 2014 • Actavis plc - Product Pipeline Review - 2014 www.aarkstore.com
Related Market Research reports: • TiGenix NV - Product Pipeline Review – 2014 • Egenix, Inc. - Product Pipeline Review – 2014 • SkyePharma PLC - Product Pipeline Review – 2014 • MediWound Ltd. - Product Pipeline Review – 2014 • BioTech Tools s.a. - Product Pipeline Review - 2014 www.aarkstore.com
Aarkstore - Epilepsy - Pipeline Review, H2 2014 www.aarkstore.com
Contact Us Office Office No. - 809, 8th Floor, B-Wing, Mahaavir Icon, Plot No.- 89 & 90, Sector-15, CBD-Belapur, Navi Mumbai – 400614, Maharashtra, India. 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 You Can Visit : http://www.aarkstore.com OR Mail us at : contact@aarkstore.com Blog : http://www.aarkstore.com/blog/ Conference : http://conference.aarkstore.com/ News : http://www.aarkstore.com/news www.aarkstore.com